Gano Kyle
Chief Executive Officer · 16 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Tax withholding | 5,378 | $124.12 | $667,517.36 | filing |
| 2026-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Tax withholding | 1,385 | $124.12 | $171,906.20 | filing |
| 2026-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Tax withholding | 1,210 | $124.12 | $150,185.20 | filing |
| 2026-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Option exercise | 2,241 | $0.00 | $0.00 | filing |
| 2026-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Option exercise | 2,566 | $0.00 | $0.00 | filing |
| 2026-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Award | 9,968 | $0.00 | $0.00 | filing |
| 2026-02-12 | NBIX | NEUROCRINE BIOSCIENCES INC | Tax withholding | 2,648 | $123.10 | $325,968.80 | filing |
| 2026-02-12 | NBIX | NEUROCRINE BIOSCIENCES INC | Option exercise | 4,907 | $0.00 | $0.00 | filing |
| 2026-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Tax withholding | 1,580 | $136.06 | $214,974.80 | filing |
| 2026-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Option exercise | 2,927 | $0.00 | $0.00 | filing |
| 2026-01-16 | NBIX | NEUROCRINE BIOSCIENCES INC | Sale | 34,588 | $132.70 | $4.6M | filing |
| 2026-01-16 | NBIX | NEUROCRINE BIOSCIENCES INC | Option exercise | 34,588 | $35.99 | $1.2M | filing |
| 2026-01-16 | NBIX | NEUROCRINE BIOSCIENCES INC | Sale | 1,812 | $132.71 | $240,478.31 | filing |
| 2026-01-16 | NBIX | NEUROCRINE BIOSCIENCES INC | Option exercise | 1,812 | $35.99 | $65,213.88 | filing |
| 2025-11-04 | NBIX | NEUROCRINE BIOSCIENCES INC | Sale | 300 | $141.97 | $42,591.00 | filing |
| 2025-11-01 | NBIX | NEUROCRINE BIOSCIENCES INC | Option exercise | 613 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.